Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BenQ Medical TechnologyROCO:4116 +0.25%86 Piotroski F-Score is 6 as of Sep. 01, 2026, which is at its 10-year median of 6.00. GuruFocus rates ROCO:4116 with a GF Score™ of 86/100 and a GF Value™ of NT$55.15 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 812 Medical Devices & Instruments companies, BenQ Medical Technology ranks better than 81.53% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
BenQ Medical Technology has an F-score of 6 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for BenQ Medical Technology's Piotroski F-Score or its related term are showing as below:
ROCO:4116'
s Piotroski F-Score Range Over the Past 10 Years
Min: 4 Med: 6 Max: 8
Current: 6
During the past 13 years, the highest Piotroski F-Score of BenQ Medical Technology was 8. The lowest was 4. And the median was 6.
BenQ Medical Technology (ROCO:4116) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
BenQ Medical Technology Piotroski F-Score Related Terms
BenQ Medical Technology Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for BenQ Medical Technology's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4116 vs ISRG, BDX, RMD: Piotroski F-Score Comparison
For the Medical Instruments & Supplies subindustry, BenQ Medical Technology's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BenQ Medical Technology Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BenQ Medical Technology's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where BenQ Medical Technology's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 27.47 + 18.668 + 12.566 + 58.981 = NT$118 Mil. Cash Flow from Operations was 118.693 + 106.957 + 29.955 + 148.511 = NT$404 Mil. Revenue was 1316.264 + 1374.779 + 1324.607 + 1429.203 = NT$5,445 Mil. Gross Profit was 427.553 + 451.805 + 427.173 + 461.472 = NT$1,768 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(5265.131 + 5239.588 + 5450.611 + 5584.802 + 5518.169) / 5 = NT$5411.6602 Mil. Total Assets at the begining of this year (Jun25) was NT$5,265 Mil. Long-Term Debt & Capital Lease Obligation was NT$837 Mil. Total Current Assets was NT$3,523 Mil. Total Current Liabilities was NT$2,324 Mil.
Net Income was 26.639 + 26.288 + 22.278 + 9.756 = NT$85 Mil.
Revenue was 1214.966 + 1319.046 + 1227.958 + 1334.988 = NT$5,097 Mil. Gross Profit was 370.701 + 406.677 + 396.2 + 413.953 = NT$1,588 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(4618.707 + 4957.227 + 5273.81 + 5297.828 + 5265.131) / 5 = NT$5082.5406 Mil. Total Assets at the begining of last year (Jun24) was NT$4,619 Mil. Long-Term Debt & Capital Lease Obligation was NT$1,097 Mil. Total Current Assets was NT$3,112 Mil. Total Current Liabilities was NT$1,965 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
BenQ Medical Technology's current Net Income (TTM) was 118.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
BenQ Medical Technology's current Cash Flow from Operations (TTM) was 404.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
BenQ Medical Technology's return on assets of this year was 0.02235177. BenQ Medical Technology's return on assets of last year was 0.01839498.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
BenQ Medical Technology's gearing of this year was 0.15470631. BenQ Medical Technology's gearing of last year was 0.21584028.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
BenQ Medical Technology's current ratio of this year was 1.51565707. BenQ Medical Technology's current ratio of last year was 1.58399327.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
BenQ Medical Technology's number of shares in issue this year was 44.683. BenQ Medical Technology's number of shares in issue last year was 44.345.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
BenQ Medical Technology's gross margin of this year was 0.32471088. BenQ Medical Technology's gross margin of last year was 0.31146637.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
BenQ Medical Technology's asset turnover of this year was 1.03413438. BenQ Medical Technology's asset turnover of last year was 1.10354651.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
0
+
0
+
1
+
0
=
6
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
BenQ Medical Technology has an F-score of 6 indicating the company's financial situation is typical for a stable company.
BenQ Medical Technology (ROCO:4116) has a Piotroski F-Score of 6 as of Sep. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on BenQ Medical Technology and its competitors. This is near median its historical median of 6.00. Over the past decade, BenQ Medical Technology's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, BenQ Medical Technology ranks #150 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 18.5%.
Is BenQ Medical Technology's Piotroski F-Score too high?
BenQ Medical Technology's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. BenQ Medical Technology's value of 6 is 20% above this industry median. Based on the distribution chart, BenQ Medical Technology ranks #150 out of 812 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BenQ Medical Technology has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BenQ Medical Technology's Piotroski F-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BenQ Medical Technology ranks #150 out of 812 companies for Piotroski F-Score. This places BenQ Medical Technology in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. BenQ Medical Technology's value of 6 is 20% above this benchmark. Historically, BenQ Medical Technology's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, BenQ Medical Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BenQ Medical Technology's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on BenQ Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BenQ Medical Technology's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BenQ Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, BenQ Medical Technology (ROCO:4116) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$55.15, compared to a current price of NT$40.05 — trading 27.4% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Medical Devices & Instruments industry median of 5.00. BenQ Medical Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For BenQ Medical Technology (ROCO:4116), the current Piotroski F-Score is 6 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?
Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued.
The current stock price of NT$40.05 is trading 27.4% below its estimated GF Value™ of NT$55.15.
GuruFocus considers BenQ Medical Technology to be Modestly Undervalued.
Key valuation signals for ROCO:4116:
Piotroski F-Score: 6 (near median its 10-year median of 6.00)
GF Value™: NT$55.15 vs. price of NT$40.05 (27.4% below fair value)
Industry Position: 20% above the Medical Devices & Instruments median (#150 of 812)
No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
86GF Score
Get the complete analysis for ROCO:4116
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4116 has been successfully added to your 
